Driven by strong organic growth, an in-licensing agreement with Sanofi, the consolidation of Mantra, and the resolution of most legal challenges, Emcure is projected...
Samir Arora cautioned investors not to get overly excited by CLSA's increased allocation to India. He believes that investors were shifting to the US,...
Samir Arora cautioned investors not to get overly excited by CLSA's increased allocation to India. He believes that investors were shifting to the US,...
Samir Arora cautioned investors not to get overly excited by CLSA's increased allocation to India. He believes that investors were shifting to the US,...